192ICM ICBIC Abstracts

Total Page:16

File Type:pdf, Size:1020Kb

192ICM ICBIC Abstracts Workshop Lecture Journal of Inorganic Biochemistry 96 (2003) 3 Structural Genomics Antonio Rosato, Magnetic Resonance Center, University of Florence, Italy To realize the true value of the wealth of data provided by genome sequencing data, it is necessary to relate them to the functional properties of the proteins they encode. Since the biological function of a protein is determined by its 3D structure, the systematic determination of proteins’ structures on a genome-wide scale is a crucial step in any (post-)genomic effort, which may (or may not) provide initial hints on the function. This is what is commonly referred to as ‘Structural Genomics’ (or Structural Proteomics). Because of the huge number of systems into question, all the complex steps necessary for structure determination must be optimized, streamlined and, possibly, robotized in order to shrink the time needed to solve each protein structure. This approach is dubbed ‘high-throughput’ (HTP) and is an intrinsic feature of Structural Genomics. What can be the relationship between Biological Inorganic Chemistry and Structural Genomics? A major challenge is that to reconcile the concept of HTP with the care that metalloproteins most often require because of their metal cofactors. The identifi cation of metalloproteins is even not explicitly taken into account in purely Structural Genomics projects, nor is any methodology particularly developed for them. To create true correlations between Biological Inorganic Chemistry and Structural Genomics it is necessary to develop new computational tools (e.g. to identify metalloproteins in databanks, or to correctly model their structures), as well as new methodological approaches to HTP metalloprotein expression/purifi cation and structural characterization. Of course, focus on the metal site, and its interplay with the protein moiety, is of fundamental importance. On the longer term, these developments will be crucial to unravel the complex mechanisms underlying the interactions between metal ions and bio-molecules in living cells, even though they may fail to provide information on the metal(s) actually bound in vivo. References: Bertini and Rosato, PNAS, 100:3601-4, 2003; Banci and Rosato, Acc.Chem.Res, 36:215-221, 2003. Plenary Lectures Journal of Inorganic Biochemistry 96 (2003) 7 Scanning Probe Microscopy and the Electrochemistry of Metalloproteins and Metalloenzymes: Seeing is Believing? Allen Hill, Oxford University, United Kingdom The development of bioelectrochemistry over the past quarter of a century has concentrated on the behaviour of metalloproteins and metalloenzymes at electrode surfaces and, of course, the applications to bioanalytical chemistry. However, our understanding of such systems rests on the behaviour of such systems at, or on, electrode surfaces. The advent of methods of applying Scanning Probe Microscopy in water opened up the possibility of studying biological molecules under conditions appropriate to their natural functions and hence one could assume that they were not signifi cantly changed in their structures or functions. Though the fi rst protein examined was the zinc-containing protein, metallothionein, we have concentrated on azurin and cytochrome P450 and its partner proteins, putidaredoxin (Pd)and putidaredoxin reductase (PdR). In particular, we have sought conditions that allow the investigation of structures of the complexes formed between cytochrome P450 and Pd and PdR. With all these expermiments, it was important to show that the proteins were still active when adsorbed on the electrode surface and, as expected, it was usually important to modify the surface with a promoter (or, more recently, a facilitator.) We are now attempting to study the electrochemistry of the proteins under these conditions and to move the proteins into organised arrays in preparation for the use of similar systems as truly molecular sensors. The investigation of the ubiquitous glucose sensor by Scanning Tunneling Microscopy under conditions closely related to those found in devices proved possible. Some New Aspects of Molecular Engineering of Heme Proteins to Manipulate Their Functions: Ligand Binding, Catalysis and Interprotein Recognition Isao Morishima, Kyoto University, Japan We have been concerned with rational redesign of the structures of heme proteins in order to better understand the chemical diversity of natural heme proteins and to generate novel heme proteins of potential utility. Detailed structural analysis of proteins have revealed that proteins structures are constructed by ‘modules’, which are compact structural units and correspond to exons on gene structure. In addition to the conventional point mutation, the approach we have developed is the ‘module’ substitution on the protein structure as the effective rational design step, and is, if necessary, followed by the second step, the point or random mutations for the fi ne-tuning. By inserting or substituting the specifi c module playing an important role in a desired function, we can expect that the starting point might jump to the goal. We have studied molecular engineering of heme proteins to better understand P450cam catalyzed oxygenation reactions with particular focus on putidaredoxin (electrondonor)-induced conformational changes of P450cam, to convert horseradish peroxidase to catalase and to position the oxidizing equivalents in peroxidase to change the reactivity. We have designed and created the calcium binding site in myoglobin in which the calcium binding module of troponin c is implanted into myoglobin and oxygen binding affi nity is modulated by calcium binding. We have also extensively studied the module-substituted chimeric globins to change the protein-protein recognition characteristics. For example, the module-substituted b subunit of hemoglobin or myoblobin having the module M4 from the a-subunit assembled with the b-subunit, indicating that the module M4 plays a crucial role in the specifi c subunit association in globins. Some examples of the chimeric myoglobin exhibiting association properties with other proteins will be presented. Some of the chimeric substitutions among different proteins with no homology have resulted in quite unstable proteins. We have developped the irrational design by the fi ne-tuning using the directed evolution, which allows us to construct novel and stable chimeric proteins between the different kinds of proteins. 8 Journal of Inorganic Biochemistry 96 (2003) Chromium in Biology – Toxicology and Nutritional Aspects Peter A Lay, University of Sydney, Australia Chromium is probably the most controversial of the transition metal ions in terms of its toxicity and nutritional value.1,2 Cr(VI) compounds constitute one of the fi rst classes of chemicals to be implicated as human carcinogens, whereas Cr(III) is considered as one of the least-toxic transition metals and its use as a dietary supplement in nutrition and diabetes treatment is both very controversial and the basis of a multi-million dollar industry.1 Apart from occupational health issues, the controversy over industrial uses of Cr(VI) has also escalated as a result of recent massive lawsuits in the USA involving environmental pollution that has adversely affected local populations.2 The literature on both the mechanisms of chromium-induced cancers and the use of Cr(III) as dietary supplements is full of diverse opinions and confl icting reports.1 The divergent opinions can, in part, be attributed to the complexity of Cr redox and substitution chemistry in vitro and in vivo and, in part, to the diverse scientifi c backgrounds from which different research groups tackle the problems posed by Cr bioinorganic chemistry. This talk will concentrate on new developments in Cr carcinogenicity and nutritional supplements and on the need to investigate such complex bioinorganic questions using a multi-disciplinary approach. This is required to provide real insights into understanding the bioinorganic chemistry of Cr (and other metals) in biology and medicine. Acknowledgments: We are grateful for fi nancial support from the Australian Research Council, National Health and Medical Research Council, the Australian Synchrotron Research Program and the Access to Major Facilities Program. We are also grateful for beamtime at the Advanced Photon Source and the Stanford Synchrotron Research Laboratory. 1 Codd, R.; Dillon, C. T.; Levina, A.; Lay, P. A. Coord. Chem. Rev. 2001, 216-217, 537-582. 2 Levina, A.; Codd, R.; Dillon, C. T.; Lay, P. A. Prog. Inorg. Chem. 2003, 51, 145-250. Radicals and Metal Centers as Spectroscopic Probes for Structure and Function of Photosynthetic Reaction Centers Wolfgang Lubitz, Max-Planck-Institut für Strahlenchemie, Mullheim, Germany The reaction centers (RCs) of photosynthetic organisms are highly complex multisubunit integral membrane proteins with several cofactors that are actively involved in the conversion of sun light into chemical energy. In oxygenic photosynthesis two photosystems (PS I and PS II) exist, which have recently been crystallized with 2.5 ≈ and 3.8 ≈ resolution, respectively [1,2]. The major pigment chlorophyll a is involved in light harvesting and excitation transfer in the antenna, and acts both as electron donor and intermediate electron acceptor in the charge separation process. The stable electron acceptors are quinone molecules coupled to a non-heme iron in PS II and three iron-sulfur clusters in PS I. Light-induced charge separation in PS II leads to oxidation of water and the release of protons and molecular
Recommended publications
  • Targeted Genes and Methodology Details for Neuromuscular Genetic Panels
    Targeted Genes and Methodology Details for Neuromuscular Genetic Panels Reference transcripts based on build GRCh37 (hg19) interrogated by Neuromuscular Genetic Panels Next-generation sequencing (NGS) and/or Sanger sequencing is performed Motor Neuron Disease Panel to test for the presence of a mutation in these genes. Gene GenBank Accession Number Regions of homology, high GC-rich content, and repetitive sequences may ALS2 NM_020919 not provide accurate sequence. Therefore, all reported alterations detected ANG NM_001145 by NGS are confirmed by an independent reference method based on laboratory developed criteria. However, this does not rule out the possibility CHMP2B NM_014043 of a false-negative result in these regions. ERBB4 NM_005235 Sanger sequencing is used to confirm alterations detected by NGS when FIG4 NM_014845 appropriate.(Unpublished Mayo method) FUS NM_004960 HNRNPA1 NM_031157 OPTN NM_021980 PFN1 NM_005022 SETX NM_015046 SIGMAR1 NM_005866 SOD1 NM_000454 SQSTM1 NM_003900 TARDBP NM_007375 UBQLN2 NM_013444 VAPB NM_004738 VCP NM_007126 ©2018 Mayo Foundation for Medical Education and Research Page 1 of 14 MC4091-83rev1018 Muscular Dystrophy Panel Muscular Dystrophy Panel Gene GenBank Accession Number Gene GenBank Accession Number ACTA1 NM_001100 LMNA NM_170707 ANO5 NM_213599 LPIN1 NM_145693 B3GALNT2 NM_152490 MATR3 NM_199189 B4GAT1 NM_006876 MYH2 NM_017534 BAG3 NM_004281 MYH7 NM_000257 BIN1 NM_139343 MYOT NM_006790 BVES NM_007073 NEB NM_004543 CAPN3 NM_000070 PLEC NM_000445 CAV3 NM_033337 POMGNT1 NM_017739 CAVIN1 NM_012232 POMGNT2
    [Show full text]
  • Role of Oxidative Stress in the Pathogenesis of Amyotrophic Lateral Sclerosis: Antioxidant Metalloenzymes and Therapeutic Strategies
    biomolecules Review Role of Oxidative Stress in the Pathogenesis of Amyotrophic Lateral Sclerosis: Antioxidant Metalloenzymes and Therapeutic Strategies Pavlína Hemerková * and Martin Vališ Department of Neurology, Charles University, Faculty of Medicine and University Hospital Hradec Kralove, 500 05 Hradec Kralove, Czech Republic; [email protected] * Correspondence: [email protected]; Tel.: +420-731-304-371 Abstract: Amyotrophic lateral sclerosis (ALS) affects motor neurons in the cerebral cortex, brainstem and spinal cord and leads to death due to respiratory failure within three to five years. Although the clinical symptoms of this disease were first described in 1869 and it is the most common motor neuron disease and the most common neurodegenerative disease in middle-aged individuals, the exact etiopathogenesis of ALS remains unclear and it remains incurable. However, free oxygen radicals (i.e., molecules containing one or more free electrons) are known to contribute to the pathogenesis of this disease as they very readily bind intracellular structures, leading to functional impairment. Antioxidant enzymes, which are often metalloenzymes, inactivate free oxygen radicals by converting them into a less harmful substance. One of the most important antioxidant enzymes is Cu2+Zn2+ superoxide dismutase (SOD1), which is mutated in 20% of cases of the familial form of ALS (fALS) and up to 7% of sporadic ALS (sALS) cases. In addition, the proper functioning of catalase and glutathione peroxidase (GPx) is essential for antioxidant protection. In this review article, we focus on the mechanisms through which these enzymes are involved in the antioxidant response to oxidative Citation: Hemerková, P.; Vališ, M. Role of Oxidative Stress in the stress and thus the pathogenesis of ALS and their potential as therapeutic targets.
    [Show full text]
  • Western Literature in Japanese Film (1910-1938) Alex Pinar
    ADVERTIMENT. Lʼaccés als continguts dʼaquesta tesi doctoral i la seva utilització ha de respectar els drets de la persona autora. Pot ser utilitzada per a consulta o estudi personal, així com en activitats o materials dʼinvestigació i docència en els termes establerts a lʼart. 32 del Text Refós de la Llei de Propietat Intel·lectual (RDL 1/1996). Per altres utilitzacions es requereix lʼautorització prèvia i expressa de la persona autora. En qualsevol cas, en la utilització dels seus continguts caldrà indicar de forma clara el nom i cognoms de la persona autora i el títol de la tesi doctoral. No sʼautoritza la seva reproducció o altres formes dʼexplotació efectuades amb finalitats de lucre ni la seva comunicació pública des dʼun lloc aliè al servei TDX. Tampoc sʼautoritza la presentació del seu contingut en una finestra o marc aliè a TDX (framing). Aquesta reserva de drets afecta tant als continguts de la tesi com als seus resums i índexs. ADVERTENCIA. El acceso a los contenidos de esta tesis doctoral y su utilización debe respetar los derechos de la persona autora. Puede ser utilizada para consulta o estudio personal, así como en actividades o materiales de investigación y docencia en los términos establecidos en el art. 32 del Texto Refundido de la Ley de Propiedad Intelectual (RDL 1/1996). Para otros usos se requiere la autorización previa y expresa de la persona autora. En cualquier caso, en la utilización de sus contenidos se deberá indicar de forma clara el nombre y apellidos de la persona autora y el título de la tesis doctoral.
    [Show full text]
  • Targeting SOD1 Reduces Experimental Non–Small-Cell Lung Cancer
    Targeting SOD1 reduces experimental non–small-cell lung cancer Andrea Glasauer, … , Andrew P. Mazar, Navdeep S. Chandel J Clin Invest. 2014;124(1):117-128. https://doi.org/10.1172/JCI71714. Research Article Oncology Approximately 85% of lung cancers are non–small-cell lung cancers (NSCLCs), which are often diagnosed at an advanced stage and associated with poor prognosis. Currently, there are very few therapies available for NSCLCs due to the recalcitrant nature of this cancer. Mutations that activate the small GTPase KRAS are found in 20% to 30% of NSCLCs. Here, we report that inhibition of superoxide dismutase 1 (SOD1) by the small molecule ATN-224 induced cell death in various NSCLC cells, including those harboring KRAS mutations. ATN-224–dependent SOD1 inhibition increased superoxide, which diminished enzyme activity of the antioxidant glutathione peroxidase, leading to an increase in intracellular hydrogen peroxide (H2O2) levels. We found that ATN-224–induced cell death was mediated through H2O2- dependent activation of P38 MAPK and that P38 activation led to a decrease in the antiapoptotic factor MCL1, which is often upregulated in NSCLC. Treatment with both ATN-224 and ABT-263, an inhibitor of the apoptosis regulators BCL2/BCLXL, augmented cell death. Furthermore, we demonstrate that ATN-224 reduced tumor burden in a mouse model of NSCLC. Our results indicate that antioxidant inhibition by ATN-224 has potential clinical applications as a single agent, or in combination with other drugs, for the treatment of patients with various forms of NSCLC, including KRAS- driven cancers. Find the latest version: https://jci.me/71714/pdf Research article Targeting SOD1 reduces experimental non–small-cell lung cancer Andrea Glasauer,1 Laura A.
    [Show full text]
  • IUGG03-Program.Pdf
    The Science Council of Japan and sixteen Japanese scientific societies will host IUGG2003, the XXIII General Assembly of the International Union of Geodesy and Geophysics. Hosts Science Council of Japan The Geodetic Society of Japan Seismological Society of Japan The Volcanological Society of Japan Meteorological Society of Japan Society of Geomagnetism and Earth, Planetary and Space Sciences Japan Society of Hydrology and Water Resources The Japanese Association of Hydrological Sciences The Japanese Society of Snow and Ice The Oceanographic Society of Japan The Japanese Society for Planetary Sciences The Japanese Society of Limnology Japan Society of Civil Engineers Japanese Association of Groundwater Hydrology The Balneological Society of Japan Japan Society of Erosion Control Engineering The Geochemical Society of Japan Special Support Hokkaido Prefecture City of Sapporo Co-Sponsor National Research Institute for Earth Science and Disaster Prevention (JSS01 Hagiwara Symposium on Monitoring and Modeling of Earthquake and Volcanic Processes for Prediction) Center for Climate System Research, University of Tokyo (JSM01 Toward High Resolution Climate Models and Earth System Models) Support Ministry of Education, Culture, Sports, Science and Technology Ministry of Economy, Trade and Industry Ministry of Land, Infrastructure and Transport Japan Marine Science and Technology Center National Institute of Advanced Industrial Science and Technology Japan Earth and Planetary Science Joint Meeting Organization Japanese Forestry Society Japan Business
    [Show full text]
  • NRF2 and the Ambiguous Consequences of Its Activation During Initiation and the Subsequent Stages of Tumourigenesis
    cancers Review NRF2 and the Ambiguous Consequences of Its Activation during Initiation and the Subsequent Stages of Tumourigenesis Holly Robertson 1,2, Albena T. Dinkova-Kostova 1 and John D. Hayes 1,* 1 Jacqui Wood Cancer Centre, Division of Cellular Medicine, Ninewells Hospital and Medical School, University of Dundee, Dundee DD1 9SY, Scotland, UK; [email protected] (H.R.); [email protected] (A.T.D.-K.) 2 Wellcome Trust Sanger Institute, Wellcome Genome Campus, Cambridge CB10 1SA, UK * Correspondence: [email protected]; Tel.: +44-(0)-1382-383182 Received: 30 October 2020; Accepted: 27 November 2020; Published: 2 December 2020 Simple Summary: Transcription factor NRF2 controls expression of antioxidant and detoxification genes. Normally, the activity of NRF2 is tightly controlled in the cell, and is continuously adjusted to ensure that cells are protected against endogenous chemicals and environmental agents that perturb the intracellular antioxidant/pro-oxidant balance (i.e., redox) that must be maintained for them to grow and survive in an appropriate manner. This tight control of NRF2 is achieved by a repressor protein called KEAP1 that perpetually targets NRF2 protein for degradation under normal conditions, but is unable to do so when challenged with oxidants or thiol-reactive chemicals. In the context of cancer, it is well known that drugs that stimulate short-term and reversible activation of NRF2 can provide protection for a limited period against exposure to chemicals that cause cancer. However, it is also becoming widely recognised that permanent hyper-activation of NRF2 resulting from somatic mutations in the gene that encodes NRF2, or in genes associated with its degradation, is frequently observed in certain cancers and associated with poor outcome.
    [Show full text]
  • Single-Cell RNA-Seq Analysis of the Brainstem of Mutant SOD1 Mice Reveals Perturbed Cell Types and Pathways of Amyotrophic Lateral Sclerosis
    HHS Public Access Author manuscript Author ManuscriptAuthor Manuscript Author Neurobiol Manuscript Author Dis. Author manuscript; Manuscript Author available in PMC 2020 September 26. Published in final edited form as: Neurobiol Dis. 2020 July ; 141: 104877. doi:10.1016/j.nbd.2020.104877. Single-cell RNA-seq analysis of the brainstem of mutant SOD1 mice reveals perturbed cell types and pathways of amyotrophic lateral sclerosis Wenting Liua, Sharmila Venugopala, Sana Majida, In Sook Ahna, Graciel Diamantea, Jason Honga, Xia Yanga,b,c,*, Scott H. Chandlera,b,* aDepartment of Integrative Biology & Physiology, University of California, 2024 Terasaki Bld, 610 Charles E. Young Dr. East, Los Angeles, USA bBrain Research Institute, University of California, Los Angeles, USA cInstitute for Quantitative and Computational Biosciences, University of California, Los Angeles, USA Abstract Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease in which motor neurons throughout the brain and spinal cord progressively degenerate resulting in muscle atrophy, paralysis and death. Recent studies using animal models of ALS implicate multiple cell-types (e.g., astrocytes and microglia) in ALS pathogenesis in the spinal motor systems. To ascertain cellular vulnerability and cell-type specific mechanisms of ALS in the brainstem that orchestrates oral-motor functions, we conducted parallel single cell RNA sequencing (scRNA-seq) analysis using the high-throughput Drop-seq method. We isolated 1894 and 3199 cells from the brainstem of wildtype and mutant SOD1 symptomatic mice respectively, at postnatal day 100. We recovered major known cell types and neuronal subpopulations, such as interneurons and motor neurons, and trigeminal ganglion (TG) peripheral sensory neurons, as well as, previously uncharacterized interneuron subtypes.
    [Show full text]
  • Diallyl Disulfide Inhibits the Proliferation of HT-29 Human Colon Cancer Cells by Inducing Differentially Expressed Genes
    MOLECULAR MEDICINE REPORTS 4: 553-559, 2011 Diallyl disulfide inhibits the proliferation of HT-29 human colon cancer cells by inducing differentially expressed genes YOU-SHENG HUANG1,2, NA XIE1,2, QI SU1, JIAN SU1, CHEN HUANG1 and QIAN-JIN LIAO1 1Cancer Research Institute, University of South China, Hengyang, Hunan 421001; 2Department of Pathology, Hainan Medical University, Haikou, Hainan 571101, P.R. China Received November 22, 2010; Accepted February 28, 2011 DOI: 10.3892/mmr.2011.453 Abstract. Diallyl disulfide (DADS), a sulfur compound Introduction derived from garlic, has been shown to have protective effects against colon carcinogenesis in several studies performed in Colon cancer is one of the major causes of cancer death rodent models. However, its molecular mechanism of action worldwide (1). An understanding of the mechanisms involved remains unclear. This study was designed to confirm the anti- in the occurrence and development of colon cancer would aid proliferative activity of DADS and to screen for differentially in its therapy. Epidemiological investigations have provided expressed genes induced by DADS in human colon cancer cells compelling evidence that environmental factors are modifiers with the aim of exploring its possible anticancer mechanisms. in colon cancer (1-3); diet has also been shown to be an impor- The anti-proliferative capability of DADS in the HT-29 human tant determinant of cancer risk and tumor behavior (3-5). colon cancer cells was analyzed by MTT assays and flow Garlic consumption is very popular all over the world. cytometry. The differences in gene expression between DADS- Epidemiological studies have shown an inverse correlation treated (experimental group) and untreated (control group) between the consumption of garlic and colon cancer in certain HT-29 cells were identified using two-directional suppression areas (6).
    [Show full text]
  • Mitigation of ALS Pathology by Neuron-Specific Inhibition of Nuclear Factor Kappa B Signaling
    The Journal of Neuroscience, June 24, 2020 • 40(26):5137–5154 • 5137 Neurobiology of Disease Mitigation of ALS Pathology by Neuron-Specific Inhibition of Nuclear Factor Kappa B Signaling Kallol Dutta,1 Sai Sampath Thammisetty,1 Hejer Boutej,1 Christine Bareil,1 and Jean-Pierre Julien1,2 1CERVO Brain Research Centre, Québec City, Québec G1J 2G3, Canada, and 2Department of Psychiatry and Neuroscience, Université Laval, Québec City, Québec G1V 0A6, Canada To investigate the role of neuronal NF-jB activity in pathogenesis of amyotrophic lateral sclerosis (ALS), we generated trans- genic mice with neuron-specific expression of a super-repressor form of the NF-jB inhibitor (IjBa-SR), which were then crossed with mice of both sexes, expressing ALS-linked gene mutants for TAR DNA-binding protein (TDP-43) and superoxide dismutase 1 (SOD1). Remarkably, neuronal expression of IjBa-SR transgene in mice expressing TDP-43A315T or TDP-43G348C mice led to a decrease in cytoplasmic to nuclear ratio of human TDP-43. The mitigation of TDP-43 neuropathology by IjBa-SR, which is likely due to an induction of autophagy, was associated with amelioration of cognitive and motor deficits as well as reduc- tion of motor neuron loss and gliosis. Neuronal suppression of NF-jB activity in SOD1G93A mice also resulted in neuroprotection with reduction of misfolded SOD1 levels and significant extension of life span. The results suggest that neuronal NF-jB signaling constitutes a novel therapeutic target for ALS disease and related disorders with TDP-43 proteinopathy. Key words: amyotrophic lateral sclerosis; frontotemporal dementia; IjB suppressor; NF-jB; superoxide dismutase; TDP-43 Significance Statement This study reports that neuron-specific expression of IkB super-repressor mitigated behavioral and pathologic changes in transgenic mouse models of amyotrophic lateral sclerosis expressing mutant forms of either Tar DNA-binding protein 43 or superoxide dismutase.
    [Show full text]
  • The Metabolites NADP+ and NADPH Are the Targets of the Circadian Protein Nocturnin (Curled)
    ARTICLE https://doi.org/10.1038/s41467-019-10125-z OPEN The metabolites NADP+ and NADPH are the targets of the circadian protein Nocturnin (Curled) Michael A. Estrella 1,4, Jin Du 1,4, Li Chen2,3,4, Sneha Rath1, Eliza Prangley1, Alisha Chitrakar1, Tsutomu Aoki1, Paul Schedl1, Joshua Rabinowitz2,3 & Alexei Korennykh1 Nocturnin (NOCT) is a rhythmically expressed protein that regulates metabolism under the control of circadian clock. It has been proposed that NOCT deadenylates and regulates 1234567890():,; metabolic enzyme mRNAs. However, in contrast to other deadenylases, purified NOCT lacks the deadenylase activity. To identify the substrate of NOCT, we conducted a mass spec- trometry screen and report that NOCT specifically and directly converts the dinucleotide NADP+ into NAD+ and NADPH into NADH. Further, we demonstrate that the Drosophila NOCT ortholog, Curled, has the same enzymatic activity. We obtained the 2.7 Å crystal structure of the human NOCT•NADPH complex, which revealed that NOCT recognizes the chemically unique ribose-phosphate backbone of the metabolite, placing the 2′-terminal phosphate productively for removal. We provide evidence for NOCT targeting to mito- chondria and propose that NADP(H) regulation, which takes place at least in part in mito- chondria, establishes the molecular link between circadian clock and metabolism. 1 216 Schultz Laboratory, Department of Molecular Biology, Princeton, NJ 08544, USA. 2 285 Frick Laboratory, Department of Chemistry, Princeton, NJ 08544, USA. 3 Lewis-Sigler Institute for Integrative Genomics, Princeton, NJ 08544, USA. 4These authors contributed equally: Michael A. Estrella, Jin Du, Li Chen. Correspondence and requests for materials should be addressed to J.R.
    [Show full text]
  • A Small Molecule Promotes Cartilage Extracellular Matrix Generation and Inhibits Osteoarthritis Development
    ARTICLE https://doi.org/10.1038/s41467-019-09839-x OPEN A small molecule promotes cartilage extracellular matrix generation and inhibits osteoarthritis development Yuanyuan Shi1,2, Xiaoqing Hu1,2, Jin Cheng1, Xin Zhang1, Fengyuan Zhao1, Weili Shi1, Bo Ren1, Huilei Yu1, Peng Yang1, Zong Li1, Qiang Liu1, Zhenlong Liu 1, Xiaoning Duan1, Xin Fu1, Jiying Zhang1, Jianquan Wang1 & Yingfang Ao1 1234567890():,; Degradation of extracellular matrix (ECM) underlies loss of cartilage tissue in osteoarthritis, a common disease for which no effective disease-modifying therapy currently exists. Here we describe BNTA, a small molecule with ECM modulatory properties. BNTA promotes gen- eration of ECM components in cultured chondrocytes isolated from individuals with osteoarthritis. In human osteoarthritic cartilage explants, BNTA treatment stimulates expression of ECM components while suppressing inflammatory mediators. Intra-articular injection of BNTA delays the disease progression in a trauma-induced rat model of osteoarthritis. Furthermore, we identify superoxide dismutase 3 (SOD3) as a mediator of BNTA activity. BNTA induces SOD3 expression and superoxide anion elimination in osteoarthritic chondrocyte culture, and ectopic SOD3 expression recapitulates the effect of BNTA on ECM biosynthesis. These observations identify SOD3 as a relevant drug target, and BNTA as a potential therapeutic agent in osteoarthritis. 1 Institute of Sports Medicine, Beijing Key Laboratory of Sports Injuries, Peking University Third Hospital, 100191 Beijing, China. 2These authors contributed equally: Yuanyuan Shi, Xiaoqing Hu. Correspondence and requests for materials should be addressed to J.W. (email: [email protected]) or to Y.A. (email: [email protected]) NATURE COMMUNICATIONS | (2019) 10:1914 | https://doi.org/10.1038/s41467-019-09839-x | www.nature.com/naturecommunications 1 ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-019-09839-x steoarthritis (OA) is the most prevalent musculoskeletal compared with vehicle (Fig.
    [Show full text]
  • Male Leaders' Challenges to Promote Women's Active Participation in Japan Male Leaders' Challenges to Promote Women's Ac
    December 2017 Male leaders’ challenges to promote women’s active participation in Japan A Group of Male Leaders Who will Create a Society in which Women Shine Gender Equality Bureau, Cabinet Office Introduction In June 2014, male leaders engaging in the promotion of active participation by women in society issued the“Declaration on Action by A Group of Male Leaders Who will Create a Society in Which Women Shine.” It has been about three and a half years since then, and over 150 people have expressed their support for the declaration. During this time, the momentum for women playing a more active role in society has grown steadily. The number of women in the workforce has increased, and the number of women in decision-making positions is slowly increasing as well. In April 2016,“The Act on Promotion of Women’s Participation and Advancement in the Workplace” was enacted. It requires large companies as well as national and local government agencies to formulate and disclose action plans and regularly disclose data on the participation and advancement of women. There are also initiatives in place to change male-oriented labor practices as well as men’s awareness and lifestyles—the largest barriers in achieving a work environment in which women thrive. However, the disparity between men and women in Japan is still large compared to other countries around the world. In order to motivate women and allow them to utilize their abilities maximally, we need to further accelerate our initiatives. In this report, we asked the leaders of organizations to share the significance of active participation by women from the perspective of management.
    [Show full text]